Conference Calendar
|
| Symbol | Last | Change | Volume (000) |
|---|---|---|---|
| ARTC | 27.29 | -0.02 | 15.3 |
| LSE:AOI | 75.00 | -7.00 | 2.5 |
| ANIK | 6.64 | +0.18 | 22.7 |
| ATEC | 6.43 | +0.38 | 262.2 |
| BMTI | 12.63 | +0.29 | 258.3 |
| CAPS | 0.94 | -0.03 | 28.1 |
| LSE:CRG | 65.00 | 67.5 | |
| CYTX | 6.02 | -1.48 | 5,703.4 |
| EXAC | 19.65 | +0.18 | 20.6 |
| LSE:IIN | 0.70 | 38.6 | |
| IART | 41.96 | +0.03 | 198.0 |
| HGR | 18.08 | +0.09 | 148.8 |
| MAKO | 13.05 | -0.08 | 299.1 |
| NUVA | 44.10 | -1.10 | 794.1 |
| OFIX | 35.38 | -0.19 | 148.5 |
| OSIR | 7.74 | -0.08 | 53.2 |
| OSTE | 4.15 | +0.03 | 62.6 |
| PCGR | 0.5199 | -0.01 | 2.1 |
| RGBO.PK | 0.235 | 0.6 | |
| RTIX | 4.28 | -0.07 | 101.8 |
| SMA | 8.84 | -0.11 | 174.4 |
| LSE:SN | 677.00 | -0.50 | 1,539.9 |
| SYK | 55.23 | -0.50 | 2,085.6 |
| TSON | 3.63 | 48.5 | |
| VIRTX:SYST | 129.10 | -0.70 | 172.3 |
| VITA | 3.75 | +0.10 | 644.8 |
| WMGI | 16.25 | +0.19 | 1,727.0 |
| ZMH | 59.24 | +2.21 | 4,746.8 |
Dental
| Symbol | Last | Change | Volume (000) |
|---|---|---|---|
| VIRTX:NOBN | 28.49 | +0.38 | 809.0 |
| STMN.SW | 261.00 | -1.00 | 16.5 |
Private Equity Research
Focused on the Orthopedics and Dental Sector
HealthpointCapital is the leading source for research on the orthopedic and dental industry's markets, major players, technologies and trends. The research team has created an unparalleled bank of intellectual capital that reflects a thorough understanding of the industry's dynamics, key strategies and valuation trends. Research insights and conclusions are central to HealthpointCapital's investment decisions. More about us...
Orthopedic & Dental Industry News
Most Recent Blog Articles Complete Archive »
Musculoskeletal News Roundup: AAOS Edition BY LAUREN UZDIENSKI
The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant more
Device Industry Seeks Cap on Healthcare Reform Fees BY LAUREN UZDIENSKI
With healthcare reform projected to cost $950 billion, the pharma, device and hospital industries have generally consented to help fund the changes - in the device industry's case, to the tune of $20 billion over the next decade, which will be realized through an excise tax proposed to be implemented in 2011. AdvaMed is pushing on behalf of the industry to lock in that $20 billion as a cap, reports Reuters. more
NYT Challenges Metal-on-Metal Hips BY LAUREN UZDIENSKI
Wear debris and surgical technique are at the center of a New York Times article on metal-on-metal total hip components, with the paper suggesting that metal-on-metal correlates to poorer outcomes and higher revision rates. The article cites a metal-on-metal revision rate of 1-3%, with women affected more frequently than men. more
Musculoskeletal News Roundup 4-Mar-10 BY LAUREN UZDIENSKI
Corin, Osteotech and Integra report 4Q . . . Baxter to acquire ApaTech for up to $330.0 million . . . Intrinsic Therapeutics closes on $18.0 million of a $20.0 million round . . . FDA schedules Orthopaedic and Rehabilitation Devices Panel meeting for Menaflex . . . Aetna and United Healthcare reverse prior policies and announce that they will cover NuVasive's XLIF . . . Congress delays Medicare pay cut more
NIH, FDA Introduce "Fast Track" Initiative for New Devices BY LAUREN UZDIENSKI
The NIH and FDA plan to collaborate on ways to bring innovative products to market sooner. 
Among other actions, the two agencies plan to create a Joint Leadership Council, which will focus on encouraging researchers to think about regulatory issues early in the technology development cycle. The council will also work to incorporate the latest scientific data into the FDA review process. more
Aetna, UHC Reverse Payment Policies for XLIF BY LAUREN UZDIENSKI
Aetna and United Healthcare both announced that they will cover XLIF, reversing non-coverage policies and allowing the procedure to shed its "investigational" status. more
Baxter to Acquire ApaTech for up to $330 million BY ARIELLA P. GOLOMB, MD
Baxter announced plans to acquire ApaTech for up to $330 million, with $240 million in cash up front (a 4x revenue multiple) and additional milestone payments of up to $90 million. more
Dental News Roundup February 2010 BY LAUREN UZDIENSKI
Dentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions." more
Musculoskeletal News Roundup 25-Feb-10 BY LAUREN UZDIENSKI
Alphatec Spine reported 4Q:09 revenues of $36.6 million, an increase of 29% from the $28.4 million reported in 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. Asian revenues were $6.6 million, an increase of 38% from the $4.8 million reported for 4Q:08. European revenues in 4Q:09 were $1.7 million. more
Sponsorships
HealthpointCapital is a proud sponsor of ArgoSpine, the premier European-based organization dedicated to research in spine surgery. ArgoSpine will be represented on our blog with selected journal articles that we believe will be especially relevant and insightful for you. Read more about our sponsorship here.
We are also a member of the Medical Device Manufacturers Association (MDMA), which champions favorable regulatory and market conditions for medical device innovators.